Ingrezza (valbenazine), an approved treatment for chorea, or uncontrolled movements, related to Huntington’s disease, shows similar effectiveness…
Articles by Marisa Wexler, MS
Being physically active is significantly associated with a delayed age of the onset of Huntington’s disease and spending more…
Ingrezza Sprinkle, a new formulation of Ingrezza (valbenazine) that’s designed to be easier to swallow, is now available in…
Significant impairments in cognitive function are evident in people with Huntington’s disease relative to healthy adults, as assessed with…
Clinical trials testing either tominersen, an experimental therapy designed to target the underlying cause of Huntington’s disease, or…
The Huntington’s disease community was encouraged to step up and get involved in observational studies to help scientists better…
Establishing exercise routines and getting support from care partners can help people with Huntington’s disease stay active and maintain…
Psychotherapy — talk therapy with a professional to help a person manage their emotional state and mental health — can…
The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) status to AMT-130, an experimental…
For people with Huntington’s disease who are struggling to get a good night’s sleep, establishing good sleep hygiene —…